cancer talk

Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.

by Jon Kelvey

Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.

by Marci A. Landsmann

Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.

Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.

by Kyle Bagenstose

An increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential for decades of life after cancer.

by Sandra Gordon

AACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.

by Thomas Celona

An expert panel at the AACR Annual Meeting discussed the difficult choices faced when cancer is diagnosed during a pregnancy and how recent laws have brought additional challenges.

by Eric Fitzsimmons

People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.

by Marci A. Landsmann

Researchers use insights from behavioral economics to encourage taking recommended actions in health care.

by Kevin McLaughlin

New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.

by Thomas Celona